13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q4 2021. See the latest, Q2 2026 →
Reported value
$34.71B
−4.8% on the quarter before
Positions
107
27 new · 16 sold out
Top 10
37.4%
of the value
Est. gain
−$2.24B
on stocks held all quarter
Est. return
−7.8%
on those stocks since Q3 2021
Positions as of Dec 31, 2021, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 64% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2021. Striped tiles are options.
Largest buys
Since Q3 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Roivant Sciences Ltd~$889.4MNew · 0.0% → 2.6%+88,238,700 shares
- Twilio~$784.9MNew · 0.0% → 2.3%+2,980,398 shares
- Boston Scientific Corp~$513.8MAdded · 0.8% → 2.3%+12,095,096 shares
- Workday~$478.5MNew · 0.0% → 1.4%+1,751,589 shares
- Aon Plc~$454.0MNew · 0.0% → 1.3%+1,510,517 shares
- T-Mobile Us Inc~$339.0MAdded · 3.6% → 4.4%+2,923,102 shares
- Rivian Automotive Inc~$332.3MNew · 0.0% → 1.0%+3,204,389 shares
- Global E Online Ltd~$319.4MNew · 0.0% → 0.9%+5,038,891 shares
- Visa Inc.~$289.3MAdded · 1.6% → 2.5%+1,334,844 shares
- Biomarin Pharmaceutical Inc~$253.6MNew · 0.0% → 0.7%+2,869,947 shares
Largest sells
Since Q3 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Fidelity Natl Information Sv~$872.7MSold out · 2.4% → 0.0%−7,172,066 shares
- Mcdonalds Corp~$544.7MCut · 2.0% → 0.7%−2,032,064 shares
- Palo Alto Networks~$489.1MCut · 1.7% → 0.6%−878,441 shares
- Snowflake~$434.4MSold out · 1.2% → 0.0%−1,436,335 shares
- Pinterest Inc~$368.4MSold out · 1.0% → 0.0%−7,230,842 shares
- Fleetcor Technologies Inc~$332.5MCut · 1.8% → 0.6%−1,485,221 shares
- Icici Bank Limited~$325.4MSold out · 0.9% → 0.0%−17,242,857 shares
- Bristol-Myers Squibb Co~$324.7MCut · 1.1% → 0.3%−5,207,645 shares
- Zoom~$308.3MSold out · 0.8% → 0.0%−1,178,992 shares
- Unitedhealth Group Inc~$283.9MSold out · 0.8% → 0.0%−726,474 shares
Holdings
As of Dec 31, 2021. Changes are in shares against Sep 30, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings IncCL A SHS · shares 0% · price −28.3% | 8.1% | $2.82B | −$1.11B | ||||||||
| General Electric CoCOM NEW · shares +6.6% · price −8.3% | 4.9% | $1.70B | −$144.9M | ||||||||
| T-Mobile Us IncCOM · shares +29% · price −9.2% | 4.4% | $1.52B | −$120.5M | ||||||||
| Humana IncCOM · shares −11% · price +19.2% | 3.6% | $1.24B | +$199.0M | ||||||||
| Brookfield Asset Mgmt IncCL A LTD VT SH · shares +3.6% · price +12.8% | 3.1% | $1.06B | +$116.7M | ||||||||
| MicrosoftCOM · shares −19% · price +19.3% | 2.8% | $986.3M | +$159.5M | ||||||||
| Parker-Hannifin CorpCOM · shares −1.4% · price +13.8% | 2.8% | $972.5M | +$117.7M | ||||||||
| AmazonCOM · shares +37% · price +1.5% | 2.7% | $927.6M | +$10.0M | ||||||||
| Roivant Sciences LtdSHS · shares New | 2.6% | $889.4M | — | ||||||||
| Visa Inc.COM CL A · shares +51% · price −2.7% | 2.5% | $860.7M | −$15.9M | ||||||||
| Api Group CorpCOM STK · shares 0% · price +26.6% | 2.5% | $859.0M | +$180.7M | ||||||||
| Adaptive Biotechnologies CorCOM · shares 0% · price −17.4% | 2.4% | $841.6M | −$177.9M | ||||||||
| Boston Scientific CorpCOM · shares +176% · price −2.1% | 2.3% | $805.5M | −$6.2M | ||||||||
| TwilioCL A · shares New | 2.3% | $784.9M | — | ||||||||
| Comcast Corp NewCL A · shares +40% · price −10.0% | 2.1% | $715.3M | −$57.0M | ||||||||
| Chubb LimitedCOM · shares +21% · price +11.4% | 2.1% | $713.7M | +$60.3M | ||||||||
| Centene Corp DelCOM · shares −13% · price +32.2% | 2.0% | $710.2M | +$173.1M | ||||||||
| Coupa Software IncCOM · shares +6.4% · price −27.9% | 1.9% | $658.8M | −$239.5M | ||||||||
| Fortive CorpCOM · shares −21% · price +8.1% | 1.9% | $647.3M | +$48.5M | ||||||||
| MetaCL A · shares +11% · price −0.9% | 1.8% | $634.5M | −$5.2M | ||||||||
| Guardant Health IncCOM · shares +3.7% · price −20.0% | 1.5% | $507.5M | −$122.3M | ||||||||
| WorkdayCL A · shares New | 1.4% | $478.5M | — | ||||||||
| Aon PlcSHS CL A · shares New | 1.3% | $454.0M | — | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price −64.4% | 1.3% | $444.0M | −$803.7M | ||||||||
| UberCOM · shares +66% · price −6.4% | 1.3% | $443.8M | −$18.3M | ||||||||
| Total · 107 positions | 100% | $34.71B | −$2.24B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2021 to Q4 2021: 79 stocks held throughout, down $2.24B (−7.8%).
- Humana Inc+$199.0M+19%
- Api Group Corp+$180.7M+27%
- Centene Corp Del+$173.1M+32%
- Microsoft+$159.5M+19%
- Parker-Hannifin Corp+$117.7M+14%
- Adaptive Biotechnologies Cor−$177.9M−17%
- Peloton Interactive Inc−$202.7M−59%
- Coupa Software Inc−$239.5M−28%
- Bridgebio Pharma Inc−$803.7M−64%
- Ginkgo Bioworks Holdings Inc−$1.11B−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |